moexipril hydrochloride 7.5 MG Oral Tablet
moexipril hydrochloride
RxCUI: 1299897
What the CMS Formulary Data Shows for moexipril hydrochloride 7.5 MG Oral Tablet
Per the CMS 2026 Part D formulary file, moexipril hydrochloride 7.5 MG Oral Tablet (RxNorm concept RXCUI 1299897, generic name moexipril hydrochloride) appears on 316 distinct formulary files spanning 4,809 Medicare Part D plan offerings - 94.9% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.3.
Real-world access to moexipril hydrochloride 7.5 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,997 Part D beneficiaries filled moexipril hydrochloride 7.5 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $1,753,234 and an average per-beneficiary annual cost of $292.35. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry moexipril hydrochloride 7.5 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 316
- Plans covering
- 4,809
- Coverage rate
- 94.9%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 5,997
- Total spending
- $1,753,234
- Avg per beneficiary
- $292.35
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering moexipril hydrochloride 7.5 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is moexipril hydrochloride 7.5 MG Oral Tablet covered by Medicare Part D?
Yes, moexipril hydrochloride 7.5 MG Oral Tablet is covered by 4,809 Medicare Part D plans (94.9% of all Part D formularies).
What tier is moexipril hydrochloride 7.5 MG Oral Tablet on Medicare Part D plans?
moexipril hydrochloride 7.5 MG Oral Tablet averages Tier 2.3 across Part D plans, ranging from Tier 1 to Tier 6.
Does moexipril hydrochloride 7.5 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for moexipril hydrochloride 7.5 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0.6%.
How much does Medicare spend on moexipril hydrochloride 7.5 MG Oral Tablet?
In 2023, total Medicare Part D spending on moexipril hydrochloride 7.5 MG Oral Tablet was $1,753,234, covering 5,997 beneficiaries. The average spend per beneficiary was $292.35.
Read our methodology - how this data is sourced, computed, and verified.